Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice

Cardiovascular Research

Volumn 69, Issue 1, 2006, Pages 245-252

  Demiot, Claire ^a   Fromy, Bérengère ^a   Saumet, Jean Louis ^a   Sigaudo Roussel, Dominique ^a  

^a Medical School   (France)

Author keywords

Blood flow; Diabetes; Endothelial function; Microcirculation; Vasodilation

Indexed keywords

ALAGEBRIUM; ANTIDIABETIC AGENT; SORBINIL; THIOCTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EVALUATION; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MOUSE; NEUROPATHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; VASODILATATION;

ACETYLCHOLINE; ALDEHYDE REDUCTASE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; DIABETES MELLITUS; DINOPROST; IMIDAZOLIDINES; LASER-DOPPLER FLOWMETRY; MALE; MICE; MICROCIRCULATION; NITRIC OXIDE SYNTHASE; NITROARGININE; OXIDATIVE STRESS; PRESSURE; PRESSURE ULCER; REGIONAL BLOOD FLOW; SKIN; THIOCTIC ACID; VASODILATION; VASODILATOR AGENTS;

EID: 29144460968     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.09.005     Document Type: Article

References (52)

1. A.J. Boulton The diabetic foot: from art to science. The 18th Camillo Golgi lecture Diabetologia 47 2004 1343 1353
2. D.G. Armstrong, L.A. Lavery, K. Holtz-Neiderer, M.J. Mohler, C.S. Wendel, and B.P. Nixon Variability in activity may precede diabetic foot ulceration Diabetes Care 27 2004 1980 1984
3. B. Fromy, P. Abraham, and J.L. Saumet Non-nociceptive capsaicin-sensitive nerve terminal stimulation allows for an original vasodilatory reflex in the human skin Brain Res 811 1998 166 168
4. B. Fromy, P. Abraham, and J.L. Saumet Progressive calibrated pressure device to measure cutaneous blood flow changes to external pressure strain Brain Res Protoc 5 2000 198 203
5. B. Fromy, S. Merzeau, P. Abraham, and J.L. Saumet Mechanisms of the cutaneous vasodilator response to local external pressure application in rats: involvement of CGRP, neurokinins, prostaglandins and NO Br J Pharmacol 131 2000 1161 1171
6. L. Fizanne, B. Fromy, M.P. Preckel, D. Sigaudo-Roussel, and J.L. Saumet Effect of isoflurane on skin-pressure-induced vasodilation J Vasc Res 40 2003 416 422
7. B. Fromy, P. Abraham, C. Bouvet, B. Bouhanick, P. Fressinaud, and J.L. Saumet Early decrease of skin blood flow in response to locally applied pressure in diabetic subjects Diabetes 51 2002 1214 1217
8. A. Koitka, P. Abraham, B. Bouhanick, D. Sigaudo-Roussel, C. Demiot, and J.L. Saumet Impaired pressure-induced vasodilation at the foot in young adults with type 1 diabetes Diabetes 53 2004 721 725
9. D. Sigaudo-Roussel, C. Demiot, B. Fromy, A. Koitka, G. Leftheriotis, and P. Abraham Early endothelial dysfunction severely impairs skin blood flow response to local pressure application in streptozotocin-induced diabetic mice Diabetes 53 2004 1564 1569
10. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
11. M.A. Yorek The role of oxidative stress in diabetic vascular and neural disease Free Radic Res 37 2003 471 480
12. J.E. Tooke, S.J. Morris, and A.C. Shore Microvascular functional abnormalities in diabetes: the role of the endothelium Diabetes Res Clin Pract 31 1996 S127 S132
13. N.N. Chan, P. Vallance, and H.M. Colhoun Nitric oxide and vascular responses in Type I diabetes Diabetologia 43 2000 137 147
14. N.E. Cameron, M.A. Cotter, M. Basso, and T.C. Hohman Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats Diabetologia 40 1997 271 281
15. L.J. Coppey, J.S. Gellett, E.P. Davidson, J.A. Dunlap, and M.A. Yorek Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve Int J Exp Diabetes Res 3 2002 21 36
16. B.H. Wolffenbuttel, C.M. Boulanger, F.R. Crijns, M.S. Huijberts, P. Poitevin, and G.N. Swennen Breakers of advanced glycation end products restore large artery properties in experimental diabetes Proc Natl Acad Sci USA 95 1998 4630 4634
17. S. Vasan, P. Foiles, and H. Founds Therapeutic potential of breakers of advanced glycation end product-protein crosslinks Arch Biochem Biophys 419 2003 89 96
18. N.E. Cameron, A.M. Jack, and M.A. Cotter Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats Free Radic Biol Med 31 2001 125 135
19. L.J. Coppey, J.S. Gellett, E.P. Davidson, and M.A. Yorek Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation Free Radic Res 37 2003 33 40
20. L.J. Coppey, J.S. Gellett, E.P. Davidson, J.A. Dunlap, D.D. Lund, and M.A. Yorek Effects of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve Diabetes 50 2001 1927 1937
21. D.W. Zochodne, L.T. Ho, and P.M. Gross Acute endoneurial ischemia induced by epineurial endothelin in the rat sciatic nerve Am J Physiol 263 1992 1806 1810
22. D.A. Armbruster Fructosamine: structure, analysis and clinical usefulness Clin Chem 33 1987 2153 2163
23. R.R. Tuck, J.D. Schmelzer, and P.A. Low Low, endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy Brain 107 1984 935 950
24. P.A. Low, R.R. Tuck, P.J. Dyck, J.D. Schmelzer, and J.K. Yao Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy Proc Nat Acad Sci USA 81 1984 6894 6898
25. I.G. Obrosova, C. Van Huysen, L. Fathallah, X.C. Cao, D.A. Greene, and M.J. Stevens An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense FASEB J 16 2002 123 125
26. M.J. Stevens, I. Obrosova, X. Cao, C. Van Huysen, and D.A. Greene Effects of dl-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy Diabetes 49 2000 1006 1015
27. M.A. Yorek, L.J. Coppey, J.S. Gellett, E.P. Davidson, and D.D. Lund Effect of fidarestat and alpha-lipoic acid on diabetes-induced epineurial arteriole vascular dysfunction Exp Diabesity Res 5 2004 123 135
28. I.G. Obrosova, P. Pacher, C. Szabo, Z. Zsengeller, H. Hirooka, and M.J. Stevens Aldose reductase inhibition counteracts oxidative-nitrosative stress and Poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications Diabetes 54 2005 234 242
29. L.J. Coppey, E.P. Davidson, J.A. Dunlap, D.D. Lund, and M.A. Yorek Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve Int J Exp Diabetes Res 1 2000 131 143
30. G.M. Pieper Enhanced unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration Diabetologia 42 1999 204 213
31. J. Skrha, M. Prazny, T. Haas, J. Kvasnicka, and B. Kalvodova Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in type 1 diabetic patients J Diabetes Complications 15 2001 234 240
32. S. Arora, P. Smakowski, R.G. Frykberg, L.R. Simeone, R. Freeman, and F.W. Lo Gerfo Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy Diabetes Care 21 1998 1339 1344
33. S. Kilo, M. Berghoff, M. Hilz, and R. Freeman Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy Neurology 54 2000 1246 1252
34. G. Kocak, and C. Karasu Elimination of*O(2)(-)/H(2)O(2) by alpha-lipoic acid mediates the recovery of basal EDRF/NO availability and the reversal of superoxide dismutase-induced relaxation in diabetic rat aorta Diabetes Obes Metab 4 2002 69 74
35. R.M. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
36. I.C. West Radicals and oxidative stress in diabetes Diabet Med 17 2000 171 180
37. P. Rosen, P.P. Nawroth, G. King, W. Moller, H.J. Tritschler, and L. Packer The role of oxidative stress in the onset and progression of diabetes and its complications Diabetes Metab Res Rev 17 2001 189 212
38. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation Circulation 99 1999 224 229
39. S. O'Byrne, P. Forte, L.J. Roberts II, J.D. Morrow, A. Johnston, and E. Anggard Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion Diabetes 49 2000 857 862
40. L. Packer, E.H. Witt, and H.J. Tritschler Alpha-lipoic acid as a biological antioxidant Free Radic Biol Med 19 1995 227 250
41. C. Lu, and Y. Liu Interactions of lipoic acid radical cations with vitamins C and E analogue and hydroxycinnamic acid derivatives Arch Biochem Biophys 406 2002 78 84
42. W. Jones, X. Li, Z.C. Qu, L. Perriott, R.R. Whitesell, and J.M. May Uptake, recycling, and antioxidant of α-lipoic acid in endothelial cells Free Radic Biol Med 33 2002 83 93
43. A. Bierhaus, S. Chevion, M. Chevion, M. Hofmann, P. Quehenberger, and T. Illmer Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells Diabetes 46 1997 1481 1490
44. F. Pricci, G. Leto, L. Amadio, C. Lacobini, S. Cordone, and S. Catalano Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C Free Radic Biol Med 35 2003 683 694
45. M.M. O'Brien, P.J. Schofield, and M.R. Edwards Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil J Neurochem 39 1982 810 814
46. C.G. Schalkwijk, C.D. Stehouwer, and V.W. Van Hinsbergh Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification Diabetes Metab Res Rev 20 2004 369 382
47. M.S. Huijberts, B.H. Wolffenbuttel, H.A. Boudier, F.R. Crijns, A.C. Kruseman, and P. Poitevin Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats J Clin Invest 92 1993 1407 1411
48. D.A. Kass, E.P. Shapiro, M. Kawaguchi, A.R. Capriotti, A. Scuteri, and R.C. deGroof Improved arterial compliance by a novel advanced glycation end-product crosslink breaker Circulation 104 2001 1464 1470
49. G.L. Bakris, A.J. Bank, D.A. Kass, J.M. Neutel, R.A. Preston, and S. Oparil Advanced glycation end-product cross-link breakers: a novel approach to cardiovascular pathologies related to the aging process Am J Hypertens 17 2004 23S 30S
50. D.L. Price, P.M. Rhett, S.R. Thorpe, and J.W. Baynes Chelating activity of advanced glycation end-product inhibitors J Biol Chem 276 2001 48967 48972
51. R. Bucala, K.J. Tracey, and A. Cerami Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes J Clin Invest 87 1991 432 438
52. N.E. Cameron, and M.A. Cotter Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition Metabolism 45 1996 1147 1152